Objective: Cytological screening was carried out in rural women of Lucknow West, India, through a camp approach to detect cervical cancer in its preinvasive phase and to see whether the primitive living conditions in the villages have any effect on the incidence of precancer and carcinoma of the cervix and the associated predisposing factors of cervical carcinogenesis. Study Design: During a span of 4 years (May 2013 to March 2017), a total of 135 camps were organized under the auspice of Era’s Lucknow Medical College and Hospital (Lucknow, India). Only 4,269 (31.2%) out of 13,500 women who were motivated and counseled attended the camp and 2,369 (55.1%) of them underwent a Pap smear examination. Results: The incidence of squamous intraepithelial lesions of the cervix (SIL) was found to be very high (18.2%) in the 2,369 women who were screened, but the majority of them were of a low grade. The SIL incidence was very high for all predisposing factors like gynaecological symptoms, age, and clinical lesions of the cervix. However, the SIL rate showed a rise with increasing parity. Candida albicans was more common in rural women (4.7%) than Trichomonas vaginalis (1.1%), and a low incidence of viral sexually transmitted diseases (STD) was seen. Conclusions: Organizing camps in the villages through proper counseling and motivation may help in the screening of larger numbers of women for early detection of cervical cancer, the adequate treatment of which will check the progression of the disease and thus minimize the incidence of carcinoma of the cervix and its associated mortality in the rural population of India.

Keywords:
Rural cervical cancer screening, Squamous intraepithelial lesions of the cervix, Risk factors, Sexually transmitted diseases
1.
Bethesda system of reporting vaginal/cervical cytological diagnosis. Acta Cytol 1993; 57: 115–120.
2.
Rajput N, Verma YS, et al: Detection of abnormal cervical cytology by Pap smear and comparison between rural and urban women. J Evol Med Dent Sci 2013; 2(41): 7923–7930.
3.
Ambedkar RKV, Srinivasmurthy BC, et al: Clinicopathological significance of Papanicolaou smear study of postmenopausal women in a rural tertiary care. Clin Cancer Investig 2015; 4: 147–151.
4.
Srivastava M, Srivastava OP, et al: Pattern of cervical smear cytology in rural medical college. Pravara Med Rev 2011; 31: 4–8.
5.
Das Gupta S, Bhattacharya S, et al: Is visual inspection with acetic acid better than cervical cytology to screen women above 40 years of age for carcinoma cervix? A cross sectional study on the proposition of screened positive women (by VIA and cervical cytology) having CIN II/III lesion on cervical biopsy: difference between two age groups and among screening methods. Arch Gynaecol Obstet 2012; 285: 17310–17316.
6.
Deodhar K, Satyanarayana K, et al: Accuracy of concurrent visual and cytology screening in detecting cervical cancer precursors in rural India. Int J Cancer 2012; 131: 954–962.
7.
Rawat K, Rawat N, et al: A study of cytological pattern of cervical Papanicolaou smears in western Rajasthan, India. Int J Reprod Contracept Obstet Gynecol 2016; 50: 3186–3190.
8.
Verma A, Verma S, et al: A study on cervical cancer screening in asymtomptomatic women using Pap smear in a tertiary care hospital of Himanchal Pradesh, India. Middle East Fertil Soc J 2017; 22: 39–42.
9.
Khasnabish S, Chakraborty R, et al: Study of cervical Pap smear and its utility in cancer screening: an experience in a tertiary care hospital of Tripura, North-Eastern State of India. J Evid Based Med Health Care 2017; 4: 2936–2939.
10.
Agarwal P, Batra S, et al: Comparison of Papanicolaou test with visual detection test in screening for cervical cancer and developing the optimal strategy for low resource settings. Int J Gyn Cancer 2010; 20: 862–868.
11.
Sharma P, Rahi M, et al: Community based cervical cancer screening programme among women of Delhi using camp approach. Indian J Commun Med 2010; 35: 86–88.
12.
Labni S, Asthan S: HPV cervical cancer screening demonstration in a rural population in North India. Eur J Obset Gynaecol Reprod 2014; 76: 75–79.
13.
Satyanarayan, L, Asthana S, et al: A comparative study of cervical cancer screening methods in a rural community setting in North India. Indian J Cancer 2014; 51: 124–128.
14.
Nene B M, Jayanth K, et al: Experience in screening for cervical cancer in rural areas of Barshi Tehsil (Maharashtra). Indian J Cancer 1994; 31: 34–40.
15.
Nikumbh DB, Nikumbh RD, et al: Cervicovaginal cytology: clinicopathological and social aspect of cervical cancer screening in rural Maharashtra, India. Int J Health Sci Res 2012; 2: 125–132.
16.
Ganeshan S, Subbiah VN, et al: Associated factors with cervical premalignant lesions among the married fishery women community of Sardas, Tamil Nadu. Asian Pac J Oncol Nurs 2015; 2: 42.
17.
Bukhari H, Saba K: Clinicopathological importance of Pap smears for diagnosis of premalignant and malignant lesions of cervix. J Cytol 2012; 29: 20–23.
18.
Arora BB, Maheshwari M, et al.: Prevalence of trichomoniasis, vaginal candidiasis, genital herpes, chlamydiasis, and actinomycosis among urban and rural women of Harayana, India. J Sex Transm Dis 2014; 2014: 963812.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.